Seeking Alpha

Morgan Stanley initiates Portola Pharmaceuticals (PTLA) at Overweight with a $32 price target...

Morgan Stanley initiates Portola Pharmaceuticals (PTLA) at Overweight with a $32 price target representing a 60% upside from Friday's close. The company went public last month in an offering led by … Morgan Stanley.
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)